IN8bio Provides INB-200 Clinical Update and Outlines 2023 Pipeline Goals
TW's Take: Gamma-Delta T-Cells is a very hot space and IN8bio is proving to be a leader here. The stock is dramatically undervalued relative...
IN8bio to Present at Biotech Showcase 2023 in San Francisco
TW's Take: expecting good news from their GBM program this coming week before they start presenting to investors in San Francisco.
NEW YORK, Jan. 03,...